Document:

exv4w5

Exhibit 4.5

          THIRD
SUPPLEMENTAL INDENTURE (this “Supplemental
Indenture”), dated as of August 4, 2009, among
GENECARE MEDICAL GENETICS CENTER, INC. and ALERE CDM LLC (collectively, the “New Guarantors”),
Subsidiaries of Inverness Medical Innovations, Inc. (or its successor) (the “Issuer”), INVERNESS
MEDICAL INNOVATIONS, INC., a Delaware corporation, each of the Guarantors (the “Existing
Guarantors”) under the Indenture referred to below, and U.S. BANK NATIONAL ASSOCIATION, as Trustee
under the Indenture referred to below (the “Trustee”).

WITNESSETH:

          WHEREAS the Issuer has heretofore executed and delivered to the Trustee an Indenture dated as
of May 12, 2009, as amended, supplemented and modified by a First Supplemental Indenture dated as
of May 12, 2009 and a Second Supplemental Indenture dated as of June 9, 2009 (as so supplemented,
the “Indenture”), by and among the Issuer, the Existing Guarantors and the Trustee, providing for
the issuance of 9.00% Senior Subordinated Notes due 2016 (the “Notes”);

          WHEREAS Section 4.13 of the Indenture provides that under certain circumstances the Issuer is
required to cause each of the New Guarantors to execute and deliver to the Trustee a supplemental
indenture pursuant to which each of the New Guarantors shall unconditionally and irrevocably
guarantee all of the Issuer’s obligations under the Notes pursuant to a guarantee on the terms and
conditions set forth herein; and

          WHEREAS pursuant to Section 9.01 of the Indenture, the Trustee, the Issuer and the Existing
Guarantors are authorized to execute and deliver this Supplemental Indenture;

          NOW THEREFORE, in consideration of the foregoing and for other good and valuable
consideration, the receipt of which is hereby acknowledged, each of the New Guarantors, the
Trustee, the Issuer and the Existing Guarantors mutually covenant and agree for the equal and
ratable benefit of the Holders as follows:

          SECTION 1. Definitions. For all purposes of this Supplemental Indenture, except as
otherwise herein expressly provided or unless the context otherwise requires: (i) the terms and
expressions used herein shall have the same meanings as corresponding terms and expressions used in
the Indenture; and (ii) the words “herein,” “hereof” and “hereby” and other words of similar import
used in this Supplemental Indenture refer to this Supplemental Indenture as a whole and not to any
particular section hereof.

          SECTION 2. Agreement to Guarantee. Each of the New Guarantors hereby unconditionally
and irrevocably agrees, jointly and severally with all other Guarantors, to guarantee the Issuer’s
obligations under the Notes and the Indenture on the terms and subject to the conditions set forth
in Article Eleven of the Indenture and to be bound by all other applicable provisions of the
Indenture.

          SECTION 3. Ratification of Indenture; Supplemental Indenture Part of Indenture.
Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all
the terms, conditions and provisions thereof shall remain in full force and effect. This

 

 

Supplemental Indenture shall form a part of the Indenture for all purposes, and every Holder
of Notes heretofore or hereafter authenticated and delivered shall be bound hereby.

          SECTION 4. Governing Law. This Supplemental Indenture shall be governed by, and
construed in accordance with, the laws of the State of New York, but without giving effect to
applicable principles of conflicts of laws to the extent that the application of the laws of
another jurisdiction would be required thereby.

          SECTION 5. Trustee Makes No Representation. The Trustee makes no representation as to
the validity or sufficiency of this Supplemental Indenture.

          SECTION 6. Counterparts. The parties may sign any number of copies of this
Supplemental Indenture. Each signed copy shall be an original, but all of them together represent
the same agreement.

          SECTION 7. Effect of Headings. The Section headings herein are for convenience only
and shall not effect the construction thereof.

[Signature Page Follows]

-2-

 

          IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed as of the date first above written.

	 	 	 	 	 
	 	NEW GUARANTORS:

GENECARE MEDICAL GENETICS CENTER, INC.,

as a New Guarantor

 	 
	 	By:  	/s/ David A. Teitel
 	 
	 	 	Name:  	David A. Teitel 	 
	 	 	Title:  	Vice President and Treasurer 	 
	 
	 	ALERE CDM LLC,

as a New Guarantor

 	 
	 	By:  	/s/ David A. Teitel
 	 
	 	 	Name:  	David A. Teitel 	 
	 	 	Title:  	Vice President, Finance 	 
	 
	 
	 	ISSUER:

INVERNESS MEDICAL INNOVATIONS, INC.

 	 
	 	By:  	/s/ David A. Teitel
 	 
	 	 	Name:  	David A. Teitel 	 
	 	 	Title:  	Chief Financial Officer and Treasurer 	 
	 

Signature Page to Third Supplemental Indenture

 

 

	 	 	 	 	 
	 	EXISTING GUARANTORS:

ADVANTAGE DIAGNOSTICS CORPORATION

ALERE LLC

ALERE HEALTHCARE OF ILLINOIS, INC.

ALERE HEALTH IMPROVEMENT COMPANY

ALERE HEALTH SYSTEMS, INC.

ALERE MEDICAL, INC.

ALERE WELLOLOGY, INC.

ALERE WOMEN’S AND CHILDREN’S HEALTH, LLC

AMEDITECH INC.

APPLIED BIOTECH, INC.

BINAX, INC.

BIOSITE INCORPORATED

CHOLESTECH CORPORATION

FIRST CHECK DIAGNOSTICS CORP.

FIRST CHECK ECOM, INC.

HEMOSENSE, INC.

IM US HOLDINGS, LLC

 	 
	 	By:  	/s/ David A. Teitel
 	 
	 	 	Name:  	David A. Teitel 	 
	 	 	Title (respectively):  Vice President; Vice
President and Treasurer; Vice President,
Finance; Vice President, Finance; Vice
President and Treasurer; Vice President and
Treasurer; Vice President, Finance; Vice
President, Finance; General Manager; Vice
President; Vice President, Finance; Vice
President, Finance; Vice President, Finance
and Chief Financial Officer; Vice President,
Finance; Vice President; Treasurer;
President 
	 
	 

Signature Page to Third Supplemental Indenture

 

 

	 	 	 	 	 
	 	EXISTING GUARANTORS (continued):

INNOVACON, INC.

INNOVATIONS RESEARCH, LLC

INNOVATIVE MOBILITY, LLC

INSTANT TECHNOLOGIES, INC.

INVERNESS MEDICAL, LLC

INVERNESS MEDICAL — BIOSTAR INC.

INVERNESS MEDICAL INNOVATIONS NORTH AMERICA, INC.

INVERNESS MEDICAL INTERNATIONAL HOLDING CORP.

INVERNESS MEDICAL INTERNATIONAL HOLDING CORP. II

ISCHEMIA TECHNOLOGIES, INC.

IVC INDUSTRIES, INC.

MATRITECH, INC.

OSTEX INTERNATIONAL, INC.

QUALITY ASSURED SERVICES, INC.

REDWOOD TOXICOLOGY LABORATORY, INC.

RTL HOLDINGS, INC.

SELFCARE TECHNOLOGY, INC.

WAMPOLE LABORATORIES, LLC

 	 
	 	By:  	/s/ David A. Teitel
 	 
	 	 	Name:  	David A. Teitel 	 
	 	 	Title (respectively):  Vice President, Finance;
Vice President, Finance; Chief Financial
Officer; Vice President, Finance; Vice
President, Finance; Vice President, Finance;
Vice President, Finance; President;
President; Vice President, Finance; Vice
President; Vice President, Finance; Vice
President, Finance; Chief Financial Officer;
Vice President, Finance; Vice President,
Finance; Vice President, Finance; Vice
President 
	 
	 

Signature Page to Third Supplemental Indenture

 

 

	 	 	 	 	 
	 	EXISTING GUARANTORS (continued):

MATRIA OF NEW YORK, INC.

 	 
	 	By:  	                /s/ Tom Underwood
 	 
	 	 	Name:  	Tom Underwood 	 
	 	 	Title:  	President 	 
	 

Signature Page to Third Supplemental Indenture

 

 

	 	 	 	 	 
	 	TRUSTEE:

U.S. BANK NATIONAL ASSOCIATION,

as Trustee

 	 
	 	By:  	/s/ Thomas E. Tabor
 	 
	 	 	Name:  	Thomas E. Tabor 	 
	 	 	Title:  	Vice President 	 
	 

Signature Page to Third Supplemental IndentureEX-10.1

Exhibit 10.1

EMPLOYMENT AGREEMENT

March 7, 2009

     The parties to this Employment Agreement (this “Agreement”) are WESCO International, Inc., a
Delaware corporation (the “Company”), and Leslie J. Parrette, Jr. (the “Executive”). The parties
wish to provide for the employment of the Executive as Senior Vice President, Legal Affairs of the
Company as of the date first above written (the “Effective Date”).

     Accordingly, the parties, intending to be legally bound, agree as follows:

1. Position and Duties.

     1.1. Titles; Reporting; Duties. During the Employment Term (as defined in Section 2),
the Company shall employ the Executive and the Executive shall serve the Company as its Senior Vice
President, Legal Affairs on an at-will basis. As Senior Vice President Legal Affairs of the
Company, the Executive shall report to and otherwise shall be subject to the direction and control
of the Chairman and/or Chief Executive Officer of the Company and shall have such duties,
responsibilities and authorities consistent with such position as may be assigned to him from time
to time. The Executive shall use his best efforts to promote the Company’s interests and he shall
perform his duties and responsibilities faithfully, diligently and to the best of his ability,
consistent with sound business practices. The Executive may be required to provide services to, or
otherwise serve as an officer or director of any direct or indirect subsidiary of the Company. The
Executive shall comply with the Company’s policies applicable to executive officers of the Company.

     1.2. Outside Activities. The Executive shall devote substantially all of his full
working time to the business and affairs of the Company. Notwithstanding the preceding sentence,
the Executive may, with the prior approval of the Chairman and/or Chief Executive Officer, engage
in such other business and charitable activities that do not violate Section 8, create a conflict
of interest or the appearance of a conflict of interest with the Company or materially interfere
with the performance of his obligations to the Company under this Agreement.

     1.3. Place of Employment. The Executive shall perform his duties under this Agreement
at the Company’s principal executive offices in Pittsburgh, Pennsylvania with the likelihood of
substantial business travel.

2. Term of Employment. The term of the Executive’s employment by the Company under this
Agreement shall be for a period of two (2) years commencing on the Effective Date (the “Employment
Term”). The Employment Term shall be subject to earlier termination under Section 5 or Section 6
or extension as described in the next sentence. The Employment Term shall be extended
automatically for an additional year as of the first anniversary of the Effective Date and as of
each subsequent annual anniversary of the Effective Date (each such anniversary is referred to
herein as an “Anniversary Date”) unless at least ninety (90) days prior to any such Anniversary
Date either party shall have given notice to the other party that the Employment Term shall not be
so extended.

3. Compensation.

     3.1. Base Salary. During the Employment Term, the Executive shall be entitled to
receive a base salary (“Base Salary”) at the annual rate of $300,000 for services rendered to the
Company or any of its direct or indirect subsidiaries, payable semi-monthly in accordance with the
Company’s regular payroll practices. The Executive’s Base Salary will be reviewed annually by the
Compensation Committee Board of Directors of the Company (the “Board”) and may be adjusted in the
Compensation Committee’s discretion.

     3.2. Annual Bonus Compensation. During the Employment Term, the Executive also shall
be entitled to receive incentive compensation (“Bonus”) in such amounts, ranging from 0% to 150% of
Base Salary, and at such times as the Compensation Committee of the Board may determine in its
discretion to award to him under any incentive compensation or other bonus plan or plans for senior
executives of the Company as may be established by

1

 

the Company from time to time (collectively, the “Executive Bonus Plan”). Such Bonus amounts
shall be based upon the degree of achievement of Company earnings, sales growth and return on
investment or other performance criteria established by the Compensation Committee of the Board.
Bonus amounts may be adjusted at the sole discretion of the Compensation Committee.

     3.3. Long-Term Incentive, Equity Awards and Stock Ownership. Annual long-term
incentive awards are made on or about July 1, and your initial grant in 2009 will have a Black –
Scholes value in the range of $225,000 — $250,000. Future grants of stock appreciation rights or
other forms of long-term incentive awards to the Executive shall be based upon performance and
award guidelines established periodically by the Compensation Committee of the Board.

Additionally, stock appreciation rights (SARs) equal to the number of shares purchased for
long-term investment within the first twelve months of employment (up to the equivalent of two
times your annual base salary) will be granted with the approval of the Compensation Committee and
the Board of Directors. The strike price will be set at the closing price on the date of purchase
on the open market in one or more transactions, not to exceed three trading days. Purchase of
shares must comply with the Company’s policy regarding insider trading. These SARs will vest
ratably over three years.

Executive will achieve and maintain an ownership portion in WESCO stock equal to two (2) times your
base salary, in accordance with company practice on or before 12/31/2012.

4. Expenses and Other Benefits.

     4.1. Reimbursement of Expenses. During the Employment Term, the Executive shall be
entitled to receive prompt reimbursement for all reasonable expenses incurred by him (in accordance
with the policies and practices presently followed by the Company or as may be established by the
Board for its senior executive officers) in performing services under this Agreement, provided that
the Executive properly accounts for such expenses in accordance with the Company’s policies.

     4.2. Employee Benefits. During the Employment Term, the Executive shall be entitled
to participate in and to receive benefits as a senior executive under all of the Company’s employee
benefit plans, programs and arrangements available to senior executives, subject to the eligibility
criteria and other terms and conditions thereof, as such plans, programs and arrangements may be
duly amended, terminated, approved or adopted by the Board from time to time. Executive shall be
entitled to four weeks of vacation annually.

     4.3. Automobile Allowance. During the Employment Term, the Executive shall be
entitled to an automobile allowance of $1,000 per month.

5. Termination of Employment.

     5.1. Death. The Executive’s employment under this Agreement shall terminate upon his
death.

     5.2. Termination by the Company. The Executive’s employment under this Agreement
shall be employment-at-will. The Company may terminate the Executive’s employment under this
Agreement at any time with or without Cause (as defined below). For purposes of this Agreement,
the Company shall have “Cause” to terminate the Executive’s employment under this Agreement and may
complete such termination within 30 days after the Company gives notice to the Executive that it
believes it has cause to terminate his employment by reason of any of the following: (a) a
material breach of this Agreement by the Executive; (b) the Executive engaging in a felony or
engaging in conduct which is in the good faith judgment of the Board, applying reasonable standards
of personal and professional conduct, injurious to the Company, its customers, employees,
suppliers, or shareholders; (c) the Executive’s inability to meet the expectations of his job
responsibilities or failure to timely and adequately perform his duties under the Agreement; or (d)
the Executive’s material breach of any manual or written policy, code or procedure of the Company.

2

 

     5.3. Termination by the Executive. The Executive may terminate his employment under
this Agreement with or without Good Reason (as defined below). If such termination is with Good
Reason, the Executive shall give the Company written notice, which shall identify with reasonable
specificity the grounds for the Executive’s resignation and provide the Company with thirty (30)
days from the day such notice is given to cure the alleged grounds for resignation contained in the
notice. A termination shall not be for Good Reason if such notice is given by the Executive to the
Company more than sixty (60) days after the occurrence of the event that the Executive alleges is
Good Reason for his termination hereunder. For purposes of this Agreement, “Good Reason” shall
mean any of the following to which the Executive shall not consent in writing: (a) a reduction in
the Executive’s Base Salary, excluding any reduction that occurs in connection with an
across-the-board reduction of the salaries of the entire senior management team; (b) a relocation
of the Executive’s primary place of employment to a location more than 50 miles from Pittsburgh,
Pennsylvania without the consent of the Executive; or (c) any material reduction in the Executive’s
offices, titles, authority, duties or responsibilities without the consent of the Executive.
Termination by the Executive for purposes of accepting employment with another organization or in
another location shall not be considered Good Reason.

     5.4. Date of Termination. “Date of Termination” shall mean the earlier of (a) the
date of expiration of the Employment Term (as set forth in Section 2) and (b) if the Executive’s
employment is terminated (i) by his death, the date of his death, or (ii) pursuant to the
provisions of Section 5.2, Section 5.3 or Section 6, as the case may be, the date on which the
Executive’s employment with the Company actually terminates.

6. Disability. The Executive shall be determined to be “Disabled” (and the provisions of
this Section 6 shall be applicable) if the Executive is unable to perform his duties under this
Agreement on essentially a full-time basis for six (6) consecutive months by reason of a physical
or mental condition (a “Disability”) and, within thirty (30) days after the Company gives notice to
the Executive that it intends to replace him due to his Disability, the Executive shall not have
returned to the performance of his duties on essentially a full-time basis. Upon a determination
that the Executive is Disabled, the Company may replace the Executive without breaching this
Agreement.

7. Compensation of the Executive upon Termination.

     7.1. Death. If the Executive’s employment under this Agreement is terminated by
reason of his death, the Company shall pay to the person or persons designated by the Executive for
that purpose in a notice filed with the Company, or, if no such person shall have been so
designated, to his estate, the amount of (a) the Executive’s accrued but unpaid Base Salary through
the Date of Termination, (b) any earned unpaid annual Bonus; provided that such Bonus is determined
to have been earned and approved by the Compensation Committee and provided that such Bonus shall
be payable at such time as the bonuses of other senior executives are payable by the Company and
(c) any other amounts that may be reimbursable by the Company to the Executive as expressly
provided under this Agreement. Any amounts payable under this Section 7.1 shall be exclusive of
and in addition to any payments which the Executive’s widow, beneficiaries or estate may be
entitled to receive pursuant to any employee benefit plan or program maintained by the Company.

     7.2. Disability. In the event of the Executive’s termination by reason of Disability
pursuant to Section 6, the Executive shall continue to receive his Base Salary as well as all
welfare benefits (on an equivalent basis to Section 7.4(a)(v) below) through the Date of
Termination; provided, however, that such Base Salary payments and continued benefits shall be
offset dollar-for-dollar by the amount of any disability income payments provided to the Executive
under any Company disability policy to the extent that such disability insurance was funded by the
Company.

     7.3. By the Company for Cause or the Executive Without Good Reason. If the
Executive’s employment is terminated by the Company for Cause, or if the Executive terminates his
employment other than for Good Reason, the Company shall pay to the Executive, within thirty (30)
days of the Date of Termination, the amount of any accrued but unpaid Base Salary through the Date
of Termination and the Company thereafter shall have no further obligation to the Executive under
this Agreement, other than for payment of any amounts accrued and vested under any employee benefit
plans or programs of the Company.

3

 

     7.4. By the Executive for Good Reason or the Company other than for Cause. 

          (a) Severance Benefits on Non-Change in Control Termination. Subject to the
provisions of Section 7.4(b) and Section 7.4(d), if prior to the occurrence of a Change in Control
or more than one (1) year after the occurrence of a Change in Control the Company terminates the
Executive’s employment without Cause, or the Executive terminates his employment for Good Reason,
then the Executive shall be entitled to the following benefits (the “Severance Benefits”):

               (i) the sum of his accrued but unpaid Base Salary through the Date of Termination, that amount
being payable in a single lump sum cash payment within thirty (30) days of the Date of Termination;

               (ii) a cash amount equal to the Executive’s pro rata Bonus for the fiscal year in which the
Date of Termination occurs, if such Bonus is deemed earned and approved by the Compensation
Committee the cash bonus will be payable at such time as bonuses for the annual period are paid to
other executive officers of the Company (such pro rata Bonus shall be based on a fraction, the
numerator of which is the number of days from the first day of the fiscal year of the Company in
which such termination occurs through and including the Date of Termination and the denominator of
which is 365);

               (iii) a cash amount equal to 1.75 times the Executive’s monthly Base Salary in effect at the
Date of Termination that amount being payable in monthly installments for eighteen (18) months
following the Date of Termination;

               (iv) the Executive shall be fully vested in his stock options, stock appreciation rights and
other equity awards except for any such stock options, stock appreciation rights and other equity
awards that will remain unvested and be forfeited if their vesting is specifically conditioned on
the achievement of operational and/or financial performance criteria that have not been met. Any
and all vested stock options, stock appreciation rights and other equity awards will remain
excercisable for a period of 60 days following the date of termination; and

               (v) the Company shall pay the full cost of the Executive’s COBRA continuation coverage as such
coverage is required to be continued under applicable law; provided, however, that, notwithstanding
the foregoing, the benefits described in this Section 7.4(a)(v) may be discontinued prior to the
end of the period provided in this subsection (v) to the extent, but only to the extent, that the
Executive receives substantially similar benefits from a subsequent employer.

          (b) Change in Control Benefits. Subject to the provisions of Section 7.4(b) and
Section 7.4(d), if within the one (1)-year period following the occurrence of a Change in Control
the Company terminates the Executive’s employment without Cause, or the Executive terminates his
employment for Good Reason, then the Executive shall be entitled to the following Severance
Benefits:

               (i) the sum of his accrued but unpaid Base Salary through the Date of Termination, that amount
being payable in a single lump sum cash payment within thirty (30) days of the Date of Termination;

               (ii) a cash amount equal to the Executive’s pro rata Bonus for the fiscal year in which the
Date of Termination occurs, if such Bonus is deemed earned and approved by the Compensation
Committee the cash bonus will be payable at such time as bonuses for the annual period are paid to
other executive officers of the Company (such pro rata Bonus shall be based on a fraction, the
numerator of which is the number of days from the first day of the fiscal year of the Company in
which such termination occurs through and including the Date of Termination and the denominator of
which is 365);

               (iii) a cash amount equal to 1.75 times the Executive’s monthly Base Salary in effect at the
Date of Termination that amount being payable in monthly installments for twenty-four (24) months
following the Date of Termination;

4

 

               (iv) the Executive shall be fully vested in his stock options, stock appreciation rights and
other equity awards, and vested stock options, stock appreciation rights and other equity awards
shall remain exercisable by the Executive for one year following the Date of Termination unless the
transaction documents relating to the Change in Control provide for the earlier expiration of such
stock options, stock appreciation rights and other equity awards; and

               (v) the Company shall pay the full cost of the Executive’s COBRA continuation coverage as such
coverage is required to be continued under applicable law; provided, however, that, notwithstanding
the foregoing, the benefits described in this Section 7.4(b)(v) may be discontinued prior to the
end of the period provided in this subsection (v) to the extent, but only to the extent, that the
Executive receives substantially similar benefits from a subsequent employer.

          (c) Definition of Change in Control. For purposes of this Agreement, a “Change in
Control” shall have the meaning given to such term in the Company’s Long-Term Incentive Plan.

          (d) Conditions to Receipt of Severance Benefits under Section 7.4(a).

               (i) Release. As a condition to receiving any Severance Benefits to which the
Executive may otherwise be entitled under Section 7.4(a) or (b), the Executive shall execute a
release (the “Release”), which shall include an affirmation of the restrictive covenants set forth
in Section 8 and a non-disparagement provision, in a form and substance satisfactory to the
Company, of any claims, whether arising under federal, state or local statute, common law or
otherwise, against the Company and its direct or indirect subsidiaries which arise or may have
arisen on or before the date of the Release, other than any claims under this Agreement or any
rights to indemnification from the Company and its direct or indirect subsidiaries pursuant to any
provisions of the Company’s (or any of its subsidiaries’) articles of incorporation or by-laws or
any directors and officers liability insurance policies maintained by the Company. If the
Executive fails or otherwise refuses to execute a Release within a reasonable time after the
Company’s request to do so, the Executive shall not be entitled to any Severance Benefits, or any
other benefits provided under this Agreement and the Company shall have no further obligations with
respect to the payment of those benefits except as may be required by law.

               (ii) Limitation on Benefits. If, following a termination of employment that gives the
Executive a right to the payment of Severance Benefits under Section 7.4(a) or (b) the Executive
violates in any material respect any of the covenants in Section 8 or as otherwise set forth in the
Release, the Executive shall have no further right or claim to any payments or other benefits to
which the Executive may otherwise be entitled under Section 7.4(a) or (b) from and after the date
on which the Executive engages in such activities and the Company shall have no further obligations
with respect to such payments or benefits; provided, however, that the covenants in Section 8 shall
continue in full force and effect.

     7.5. Severance Benefits Not Includable for Employee Benefits Purposes. Except to the
extent the terms of any applicable benefit plan, policy or program provide otherwise, any benefit
programs of the Company that takes into account the Executive’s income shall exclude any and all
severance payments and benefits provided under this Agreement.

     7.6. Exclusive Benefits. The Severance Benefits payable under Section 7.4(a) and (b)
if they become applicable under the terms of this Agreement, shall be in lieu of any other
severance or similar benefits that would otherwise be payable under any other agreement, plan,
program or policy of the Company.

     7.7 Certain Additional Payments by the Company.

          (a) Calculation of Gross-Up Payment. Notwithstanding anything in this Agreement to
the contrary, the Company’s regular outside independent public accounting firm or its regular
outside law firm (the “Professional Firm”) shall determine, promptly following the occurrence of a
Change in Control, whether any economic benefit, payment or distribution by the Company to or for
the benefit of the Executive, whether paid, payable, distributed or distributable pursuant to the
terms of this Agreement or otherwise (a “Payment”), would be subject to the excise tax imposed by
Section 4999 of the Internal Revenue Code of 1986, as amended (the “Code”),

5

 

(such excise tax referred to in this Agreement as the “Excise Tax”). In the event it is determined
that any Payments would be subject to the Excise Tax, then the Executive shall be entitled to
receive an additional payment (a “Gross-Up-Payment”) in an amount such that after payment by the
Executive of all applicable federal, state and local income and excise taxes, the Executive retains
an amount equal to the amount he would have retained had one-half (1/2) of the Excise Tax been
imposed upon the Payment; provided, however, that the foregoing gross-up provision shall not apply
in the event that the Professional Firm determines that the benefits to the Executive under this
Agreement on an after-tax basis (i.e., after federal, state and local income and excise taxes) if
such provision is not applied would exceed the after-tax benefits to the Executive if Payments were
reduced (but not below zero) such that the value of the aggregate Payments were one dollar ($1)
less than the maximum amount of Payments which the Executive may receive without becoming subject
to the tax imposed by Section 4999 of the Code. The initial Gross-Up Payment, if any, as
determined pursuant to this Section 7.7(a), shall be paid to the Executive within thirty (30) days
of the Date of Termination or, if later, within five (5) business days of the receipt of the
Professional Firm’s determination. With respect to all determinations made by the Professional
Firm under this Section 7.7, the Professional Firm shall provide detailed supporting calculations
both to the Company and the Executive within thirty (30) business days of the Date of Termination,
if applicable, or such earlier time as is requested by the Company. All determinations by the
Professional Firm under this Agreement shall be binding upon the Company and the Executive.

          (b) Underpayment. As a result of the uncertainty in the application of Section 4999
of the Code at the time of the initial determination by the Firm, it is possible that Gross-Up
Payments that have not been made by the Company should have been made (“Underpayment”). In the
event that the Executive is required to make a payment of any Excise Tax, the Professional Firm
shall determine the amount of the Underpayment that has occurred and any such Underpayment shall be
promptly paid by the Company to or for the benefit of the Executive.

     7.8 Consulting and Cooperation. In connection with the Executive’s termination of
employment, at the Company’s request, the Executive shall enter into an agreement with the Company
under which, for a period of up to twenty-four (24) months following the Date of Termination, the
Executive shall consult and cooperate with the Company and its representatives with respect to such
matters, and for such compensation, as the parties may mutually agree.

8. Restrictive Covenants.

     8.1. Confidential Information. The Executive hereby acknowledges that in connection
with his employment by the Company he will be exposed to and may obtain certain information
(including, without limitation, procedures, memoranda, notes, records and customer and supplier
lists whether such information has been or is made, developed or compiled by the Executive or
otherwise has been or is made available to him) regarding the business and operations of the
Company and its subsidiaries or affiliates. The Executive further acknowledges that such
information and procedures are unique, valuable, considered trade secrets and deemed proprietary by
the Company. For purposes of this Agreement, such information and procedures shall be referred to
as “Confidential Information.” The Executive agrees that all Confidential Information is and shall
remain the property of the Company. The Executive further agrees, except as otherwise required by
law and for disclosures occurring in the good faith performance of his duties for the Company,
while employed by the Company hereunder and thereafter, to hold in the strictest confidence all
Confidential Information, and not to, directly or indirectly, duplicate, sell, use, lease,
commercialize, disclose or otherwise divulge to any person or entity any portion of the
Confidential Information or use any Confidential Information for his own benefit or profit or allow
any person, entity or third party, other than the Company and authorized executives of the same, to
use or otherwise gain access to any Confidential Information.

     8.2. Return of Property. Upon the termination of his employment with the Company or
upon the request of the Company at any time, the Executive shall promptly deliver to the Company,
and shall retain no copies of, any written materials, records and documents made by the Executive
or coming into his possession concerning the business or affairs of the Company or its direct or
indirect subsidiaries; provided, however, that the Executive shall be permitted to retain copies of
any documents or materials of a personal nature or otherwise related to the Executive’s rights
under this Agreement.

6

 

     8.3. Non Competition. During the Employment Term and for a period of twenty-four (24)
months after the Date of Termination, the Executive shall not, unless he receives the prior written
consent of the Company, directly or indirectly, own an interest in, manage, operate, join, control,
lend money or render financial or other assistance to, participate in or be connected with, as an
officer, employee, partner, stockholder, consultant or otherwise, or engage in any activity or
capacity (collectively, the “Competitive Activities”) with respect to any individual, partnership,
limited liability company, firm, corporation or other business organization or entity (each, a
“Person”), that is engaged directly or indirectly in the distribution of electrical construction
products or electrical and industrial maintenance, repair and operating supplies, or the provision
of integrated supply services, or that is in competition with any of the business activities of the
Company or its direct or indirect subsidiaries anywhere in the world; provided, however, that the
foregoing (a) shall not apply with respect to any line-of-business in which the Company or its
direct or indirect subsidiaries was not engaged on or before the Date of Termination, and (b) shall
not prohibit the Executive from owning, or otherwise having an interest in, less than one percent
(1%) of any publicly-owned entity or three percent (3%) of any private equity fund or similar
investment fund that invests in companies engaged in the distribution of electrical construction
products or electrical and industrial maintenance, repair and operating supplies, or the provision
of integrated supply services, provided the Executive has no active role with respect to any
investment by such fund in any Person referred to in this Section 8.3.

     8.4. Non-Solicitation. During the Employment Term and for a period of twenty-four
(24) months after the Date of Termination, the Executive shall not, whether for his own account or
for the account of any other Person (other than the Company or its direct or indirect
subsidiaries), intentionally solicit, endeavor to entice away from the Company or its direct or
indirect subsidiaries, or otherwise interfere with the relationship of the Company or its direct or
indirect subsidiaries with, (a) any person who is employed by the Company or its direct or indirect
subsidiaries (including any independent sales representatives or organizations), or (b) any client
or customer of the Company or its direct or indirect subsidiaries.

     8.5. Assignment of Developments. If at any time or times during the Executive’s
employment, whether during work hours or off-duty hours, the Executive shall (either alone or with
others) make, conceive, create, discover, invent or reduce to practice any Development (as defined
below) that (i) relates to the business of the Company or any customer of or supplier to the
Company or any of the products or services being developed, manufactured or sold by the Company or
which may be used in relation therewith; or (ii) results from tasks assigned to the Executive by
the Company; or (iii) results from the use of premises or personal property (whether tangible or
intangible) owned, leased or contracted for by the Company, then all such Developments and the
benefits thereof are and shall immediately become the sole and absolute property of the Company and
its assigns, as works made for hire or otherwise. The term “Development” shall mean any invention,
modification, discovery, design, development, improvement, process, software program, work of
authorship, documentation, technique, know-how, trade secret or intellectual property right
whatsoever or any interest therein (whether or not patentable or registerable under copyright,
trademark or similar statutes or subject to analogous protection). The Executive shall promptly
disclose to the Company (or any persons designated by it) each such Development. The Executive
hereby assign all rights (including, but not limited to, rights to inventions, patentable subject
matter, copyrights and trademarks) the Executive may have or may acquire in the Developments and
all benefits and/or rights resulting therefrom to the Company and its assigns without further
compensation and shall communicate, without cost or delay, and without disclosing to others the
same, all available information relating thereto (with all necessary plans and models) to the
Company.

     8.6. Injunctive Relief. The Executive acknowledges that a breach of any of the
covenants contained in this Section 8 may result in material, irreparable injury to the Company for
which there is no adequate remedy at law, that it shall not be possible to measure damages for such
injuries precisely and that, in the event of such a breach or threat of breach, the Company shall
be entitled to obtain a temporary restraining order and/or a preliminary or permanent injunction
restraining the Executive from engaging in activities prohibited by this Section 8 or such other
relief as may be required to specifically enforce any of the covenants in this Section 8. To the
extent that the Company seeks a temporary restraining order (but not a preliminary or permanent
injunction), the Executive agrees that a temporary restraining order may be obtained ex parte.

     8.7. Adjustment of Covenants. The parties consider the covenants and restrictions
contained in this Section 8 to be reasonable. However, if and when any such covenant or
restriction is found to be void or unenforceable and would have been valid had some part of it been
deleted or had its scope of application been

7

 

modified, such covenant or restriction shall be deemed to have been applied with such
modification as would be necessary and consistent with the intent of the parties to have made it
valid, enforceable and effective.

9. Miscellaneous.

     9.1. Assignment; Successors; Binding Agreement. This Agreement may not be assigned by
either party, whether by operation of law or otherwise, without the prior written consent of the
other party, except that any right, title or interest of the Company arising out of this Agreement
may be assigned to any corporation or entity controlling, controlled by, or under common control
with the Company, or succeeding to the business and substantially all of the assets of the Company
or any affiliates for which the Executive performs substantial services. Subject to the foregoing,
this Agreement shall be binding upon and shall inure to the benefit of the parties and their
respective heirs, legatees, devisees, personal representatives, successors and assigns.

     9.2. Modification and Waiver. Except as otherwise provided below, no provision of
this Agreement may be modified, waived, or discharged unless such waiver, modification or discharge
is duly approved by the Board and is agreed to in writing by the Executive and such officer(s) as
may be specifically authorized by the Board to effect it. Notwithstanding the foregoing, in the
event that the provisions of the Company’s Corporate Governance Guidelines related to executive
employment agreements are revised during the Employment Term, the Company may make changes to this
Agreement, without the consent of the Executive, in order to conform this Agreement with such
revised Guidelines. No waiver by any party of any breach by any other party of, or of compliance
with, any term or condition of this Agreement to be performed by any other party, at any time,
shall constitute a waiver of similar or dissimilar terms or conditions at that time or at any prior
or subsequent time.

     9.3. Entire Agreement. This Agreement embodies the entire understanding of the
parties hereof, and supersedes all other oral or written agreements or understandings between them
regarding the subject matter hereof. No agreement or representation, oral or otherwise, express or
implied, with respect to the subject matter of this Agreement, has been made by either party which
is not set forth expressly in this Agreement.

     9.4. Governing Law. The validity, interpretation, construction and performance of
this Agreement shall be governed by the laws of the Commonwealth of Pennsylvania other than the
conflict of laws provision thereof.

     9.5. Consent to Jurisdiction and Service of Process.

          (a) Disputes Other Than Those Under Section 8. In the event of any dispute relating
to this Agreement, other than a dispute relating solely to Section 8, the parties shall use their
best efforts to settle the dispute, claim, question, or disagreement. To this effect, they shall
consult and negotiate with each other in good faith and, recognizing their mutual interests,
attempt to reach a just and equitable solution satisfactory to both parties. If such a dispute
cannot be settled through negotiation, the parties agree first to try in good faith to settle the
dispute by mediation administered by the American Arbitration Association under its Commercial
Mediation Rules before resorting to arbitration, litigation, or some other dispute resolution
procedure. If the parties do not reach such solution through negotiation or mediation within a
period of sixty (60) days, then, upon notice by either party to the other, all disputes, claims,
questions, or differences shall be finally settled by arbitration administered by the American
Arbitration Association in accordance with the provisions of its Commercial Arbitration Rules. The
arbitrator shall be selected by agreement of the parties or, if they do not agree on an arbitrator
within thirty (30) days after either party has notified the other of his or its desire to have the
question settled by arbitration, then the arbitrator shall be selected pursuant to the procedures
of the American Arbitration Association (the “AAA”) in Pittsburgh, Pennsylvania. The determination
reached in such arbitration shall be final and binding on all parties. Enforcement of the
determination by such arbitrator may be sought in any court of competent jurisdiction. Unless
otherwise agreed by the parties, any such arbitration shall take place in Pittsburgh, Pennsylvania,
and shall be conducted in accordance with the Commercial Arbitration Rules of the AAA.

          (b) Disputes Under Section 8. In the event of any dispute, controversy or claim
between the Company and the Executive arising out of or relating to the interpretation, application
or enforcement of the provisions of Section 8, the Company and the Executive agree and consent to
the personal jurisdiction of the County Courts in Allegheny County, Pennsylvania and/or the United
States District Court for the Western District of

8

 

Pennsylvania for resolution of the dispute, controversy or claim, and that those courts, and
only those courts, shall have exclusive jurisdiction to determine any dispute, controversy or claim
related to, arising under or in connection with Section 8 of this Agreement. The Company and the
Executive also agree that those courts are convenient forums for the parties to any such dispute,
controversy or claim and for any potential witnesses and that process issued out of any such court
or in accordance with the rules of practice of that court may be served by mail or other forms of
substituted service to the Company at the address of its principal executive offices and to the
Executive at his last known address as reflected in the Company’s records.

     9.6. Withholding of Taxes. The Company shall withhold from any amounts payable under
the Agreement all federal, state, local or other taxes as legally shall be required to be withheld.

     9.7. Notice. All notices, requests, demands and other communications hereunder shall
be in writing and shall be deemed to have been duly given if delivered by hand, mailed within the
continental United States by first class certified mail, return receipt requested, postage prepaid
or sent via a nationally-recognized overnight courier or by facsimile transmission, addressed as
follows:

             (a)     to the Company, to:

  WESCO International, Inc.

  Suite 700

  225 West Station Square Drive

  Pittsburgh, PA 15219

  Attention: Law Department

             (b)     to the Executive, to:

  Leslie J. Parrette, Jr.

  3338 Peachtree Road, N.E.

  Unit No. 2801

  Atlanta, GA 30326

Addresses may be changed by written notice sent to the other party at the last recorded address of
that party.

     9.8. Severability. The invalidity or unenforceability of any provision or provisions
of this Agreement shall not affect the validity or enforceability of any other provision of this
Agreement, which shall remain in full force and effect.

     9.9. Counterparts. This Agreement may be executed in one or more counterparts, each
of which shall be deemed to be an original but all of which together shall constitute one and the
same instrument.

     9.10. Headings. The headings used in this Agreement are for convenience only, do not
constitute a part of the Agreement, and shall not be deemed to limit, characterize, or affect in
any way the provisions of the Agreement, and all provisions of the Agreement shall be construed as
if no headings had been used in the Agreement.

     9.11. Construction. As used in this Agreement, unless the context otherwise requires:
(a) the terms defined herein shall have the meanings set forth herein for all purposes; (b)
references to “Section” are to a section hereof; (c) “include,” “includes” and “including” are
deemed to be followed by “without limitation” whether or not they are in fact followed by such
words or words of like import; (d) “writing,” “written” and comparable terms refer to printing,
typing, lithography and other means of reproducing words in a visible form; (e) “hereof,” “herein,”
“hereunder” and comparable terms refer to the entirety of this Agreement and not to any particular
section or other subdivision hereof or attachment hereto; (f) references to any gender include
references to all genders; and (g) references to any agreement or other instrument or statute or
regulation are referred to as amended or supplemented from time to time (and, in the case of a
statute or regulation, to any successor provision).

9

 

     IN WITNESS WHEREOF, the parties have duly executed this Agreement on the date and year first
above written.

	 	 	 	 	 
	 	WESCO INTERNATIONAL, INC

 	 
	 	By:  	/s/ Stephen A. Van Oss
 	 
	 	 	 	 
	 	 	 	 
	 

	 	 	 
	 

	 	Title: Director and Senior Vice President and Chief Financial and
Administrative Officer

	 	 	 	 	 
	 	EXECUTIVE

 	 
	 	/s/ Leslie J. Parrette, Jr.
 	 
	 	Leslie J. Parrette, Jr. 	 
	 	 	 
	 

10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}]]